STOCKSCOPE

ASX Finds Its Footing as Oil Retreats, but Wall Street Faces a Crucial Week

Mark Elzayed

Mark Elzayed

CIO at Vestra Capital

Published:26 Oct 2026
ASX Finds Its Footing as Oil Retreats, but Wall Street Faces a Crucial Week

Australian equities: what moved the ASX 200?

The Australian sharemarket began the week on a cautiously positive note, with the S&P/ASX 200 rising approximately 0.2% on Monday, 26 October, to around 8,810 points. Gold, metals and mining shares helped support the market, while the pullback in oil prices offered some relief after last week's sharp rally. The modest gain suggests market participants are still weighing opportunities in resource stocks against persistent inflation and interest rate concerns.

Zip Co (ASX: ZIP) surged 13.01% to $1.65, while PLS Group (ASX: PLS) climbed 8.78% to $2.85 and AP Eagers (ASX: APE) gained 7.42% to $19.97. PLS Group's advance highlighted renewed strength in lithium-related shares, although sustained gains will depend on the lithium price outlook and evidence of improving industry fundamentals.

Not everything participated in the recovery. Tuas (ASX: TUA) plunged 31.32% to $1.25, while Temple & Webster Group (ASX: TPW) fell 7.37% to $5.03. The divergence between resource-related gains and sharp individual stock declines reinforces the importance of company-specific developments in an otherwise relatively calm session.

The Australian dollar, bonds and the RBA

The Australian dollar traded around USD 0.70, with currency movements remaining sensitive to commodity prices, US interest rates and global risk appetite.

Australian government bond yields remained elevated. The two-year yield was around 4.91%, while the 10-year yield stood near 5.17%. These levels matter because higher borrowing costs can constrain household spending, pressure property valuations and reduce the present value of future corporate earnings.

The Reserve Bank of Australia's cash rate stands at 4.60%. With inflation risks complicated by elevated energy prices, the central bank faces a difficult balance between containing price pressures and avoiding an unnecessary slowdown in economic activity. This week's domestic inflation data will be important in assessing whether restrictive monetary policy needs to remain in place for longer.

Global markets: China, Asia and Europe

Asian markets were mixed on Monday. Japan's Nikkei 225 slipped 0.1%, South Korea's Kospi dropped 1.1%, and China's Shanghai Composite fell 0.4%. Hong Kong's Hang Seng gained 0.2%.

The pullback in Chinese equities raises questions about the strength of the recovery in the world's second-largest economy. For Australia, the crucial issue remains whether policy support can translate into stronger construction, industrial activity and commodity demand. Announcements of stimulus may improve sentiment, but sustained gains in iron ore and copper ultimately require evidence of stronger consumption and investment.

European equities also faced pressure from rising energy costs and elevated government bond yields. The combination complicates the outlook for businesses that cannot easily pass higher input costs on to customers.

Wall Street: US stocks and the Federal Reserve

US markets closed lower on Friday, extending a volatile week. The S&P 500 fell 0.52% to 7,623.68, the Nasdaq Composite lost 0.21% to 25,955.34, and the Dow Jones Industrial Average dropped 1.23% to 52,215.16.

Technology shares remain under scrutiny as market participants question whether enormous spending on artificial intelligence will generate sufficient earnings and cash flow. Upcoming results from Alphabet, Microsoft and Amazon could provide important evidence on the commercial returns from that spending.

The US 10-year Treasury yield approached 4.99%, adding another challenge for equity valuations. The Federal Reserve's policy meeting on Wednesday, 28 October, is the week's central event. Markets broadly expect rates to remain unchanged, leaving attention on the accompanying guidance and the outlook for December.

Commodities: gold, oil and industrial metals

Oil remains the biggest potential complication for the global economic outlook. Brent crude surged to USD 116.72 a barrel on Friday, its highest level since June 2022, before retreating towards USD 110 on Monday. The decline offers some relief, but prices remain elevated amid severe supply disruptions linked to the US war with Iran.

Gold futures traded around USD 4,027 an ounce, recovering modestly as market participants assessed interest rates, currency movements and geopolitical risks. Gold's resilience is notable given elevated bond yields, which typically increase the opportunity cost of holding the metal.

Copper and lithium-related shares also warrant attention as China-related demand expectations remain central to the outlook for Australian miners. A sustained recovery will require more than short-term buying: improving demand, tighter supply and better pricing power must support earnings.

What to watch next

The immediate focus is the Federal Reserve meeting on Wednesday, followed by US third-quarter GDP and September personal consumption expenditures inflation data on Thursday. Major technology earnings could also reshape sentiment towards growth stocks and the broader market.

In Australia, the latest inflation readings will help determine whether the RBA's restrictive policy stance remains appropriate. A softer inflation outcome could support bonds and interest-sensitive equities, while stronger-than-expected price pressures could renew pressure on valuations.

Our view is that the market is approaching a critical test. Lower oil prices would ease one of the main threats to inflation, but persistent energy disruptions and high bond yields could quickly undermine the recovery. This week's evidence on inflation, central bank policy and technology earnings should help determine which force dominates.

Mark Elzayed

Mark Elzayed

(CIO at Vestra Capital)

Mark Elzayed is a prominent Australian financial executive and portfolio strategist with over a decade of hands-on capital markets experience. Having successfully managed over $100M+ in FUM across volatile economic cycles, Mark founded Vestra Capital to democratize institutional-grade quantitative strategies and privileged ASX deal flow for Australian investors.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...